Clinical Trial

Optimal Pacing Rate for Cardiac Resynchronization Therapy

Study acronym: OPT-RATE AF
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 15, 2024 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, randomized crossover study. The objective of the study is to determine if a pacing rate of 80 beats per minute (bpm) improves exercise tolerance during the 6-minute walk test. The investigators will randomly assign half of the participants to a starting rate of 60 bpm and then switch them to a rate of 80 bpm for 3 months, and vice versa.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-03.
Trial Details
NCT Number NCT06445439
Lead Sponsor Medstar Health Research Institute
Collaborators: Medtronic
Conditions Atrial Fibrillation, Persistent
Enrollment 60 participants
Start Date 2023-12-19
Primary Completion 2025-08 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2024-10-15